Page last updated: 2024-09-02

bifendate and tyrosine

bifendate has been researched along with tyrosine in 1 studies

Compound Research Comparison

Studies (bifendate)	Trials (bifendate)	Recent Studies (post-2010) (bifendate)	Studies (tyrosine)	Trials (tyrosine)	Recent Studies (post-2010) (tyrosine)
124	8	43	44,273	846	8,225

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, G; Chen, Y; Feng, J; Gu, X; Lin, J; Lu, B; Peng, H; Ren, Z; Zhang, Y	1

Other Studies

1 other study(ies) available for bifendate and tyrosine

Article	Year
Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells. Journal of cellular and molecular medicine, 2016, Volume: 20, Issue:6 Topics: Antineoplastic Agents; Apoptosis; ATP-Binding Cassette Transporters; Biphenyl Compounds; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; K562 Cells; Mitochondria; NF-kappa B; Nitric Oxide; Proto-Oncogene Proteins c-akt; RNA, Messenger; Tyrosine	2016

Article

Year

Anticancer efficacy of a nitric oxide-modified derivative of bifendate against multidrug-resistant cancer cells.

Journal of cellular and molecular medicine, 2016, Volume: 20, Issue:6

Topics: Antineoplastic Agents; Apoptosis; ATP-Binding Cassette Transporters; Biphenyl Compounds; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Extracellular Signal-Regulated MAP Kinases; HEK293 Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; K562 Cells; Mitochondria; NF-kappa B; Nitric Oxide; Proto-Oncogene Proteins c-akt; RNA, Messenger; Tyrosine

2016